SeaStar Medical Holding FDA Grants SeaStar Medicals Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

  • Kevin Chung

Press/Media

Period18 Oct 2023

Media coverage

1

Media coverage

  • TitleSeaStar Medical Holding FDA Grants SeaStar Medicals Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date18/10/23
    PersonsKevin Chung
View all 1
View less